CEO Bill Anderson highlighted the agricultural business’s resilience as group sales reached €9.66bn in the third quarter, with the company expressing confidence in meeting its upgraded 2025 guidance despite dynamic market conditions
The Bayer Group said it remains “well on track” after revealing its results for the third quarter of the year.
Speaking while presenting the company’s third quarter statement, CEO Bill Anderson highlighted the resilience of the agricultural business.
“Overall, in a pivotal year, we’re in a strong position to deliver the 2025 group guidance we upgraded last quarter,” he said.
Group sales came in at €9.66bn in the quarter, up 0.9 per cent on a currency- and portfolio-adjusted basis, but down 3.1 per cent overall from the €9.968bn recorded last year.
In Bayer’s agricultural business, sales increased by 1.3 per cent on a currency- and portfolio-adjusted basis to €3.858bn.
Total group EBITDA before special items rose by 20.8 per cent to €1.511bn, mainly thanks to earnings growth at the Crop Science Division and in the Reconciliation.
Bayer’s net loss amounted to €963mn, an improvement on the loss of €4.183bn in the corresponding period last year.
Looking ahead, chief financial officer Wolfgang Nickl outlined Bayer’s prospects for 2026, including a look at the Crop Science division.
“While the agricultural market outlook remains quite dynamic, we look forward to bringing innovation to farmers and pursuing our profitability goals,” he noted.
